These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11029776

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Recurrent malignant proliferating trichilemmal tumor with lymph node metastasis in a young woman.
    Dubhashi SP, Jadhav SK, Parasnis A, Patil CS.
    J Postgrad Med; 2014; 60(4):400-2. PubMed ID: 25370551
    [Abstract] [Full Text] [Related]

  • 24. Management of 3 Proliferating Pilar Tumors: Definition, Differential Diagnosis, and Treatment Options.
    Alarcón Pérez CE, Gómez Ángulo D, Olmos Pérez M, Mora Hernández O, Morales SD.
    Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):850-854. PubMed ID: 31151667
    [Abstract] [Full Text] [Related]

  • 25. Coexistence of tumor of the follicular infundibulum with an unusual trichilemmal tumor.
    Inaloz HS, Inaloz SS, Unal B, Eralp A.
    Am J Dermatopathol; 2002 Oct; 24(5):406-8. PubMed ID: 12357202
    [Abstract] [Full Text] [Related]

  • 26. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.
    Dees EC, Shulman LN, Souba WW, Smith BL.
    Ann Surg; 1997 Sep; 226(3):279-86; discussion 286-7. PubMed ID: 9339934
    [Abstract] [Full Text] [Related]

  • 27. Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes.
    Ogawa Y, Nishioka A, Inomata T, Yokota N, Sasaki T, Terashima M, Yoshida S, Tanaka Y, Tohchika N.
    Oncol Rep; 1999 Sep; 6(4):801-5. PubMed ID: 10373660
    [Abstract] [Full Text] [Related]

  • 28. [A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy].
    Itoshima T, Yamamoto T, Kasamatsu T, Fujino H, Yamamoto H, Morita Y, Kodama M.
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1331-3. PubMed ID: 9279355
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
    Mori K, Chiba N, Yamamoto Y, Yonekawa H.
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2565-8. PubMed ID: 12506484
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Malignant proliferating trichilemmal tumour: a case report.
    Fernandez SH.
    Malays J Pathol; 1999 Dec; 21(2):117-21. PubMed ID: 11068417
    [Abstract] [Full Text] [Related]

  • 34. Malignant pilar tumor of the scalp: a case report and review of literature.
    Siddha M, Budrukkar A, Shet T, Deshpande M, Basu A, Patil N, Bhalavat R.
    J Cancer Res Ther; 2007 Dec; 3(4):240-3. PubMed ID: 18270401
    [Abstract] [Full Text] [Related]

  • 35. Malignant proliferating trichilemmal tumor of the lower eyelid.
    Lee SJ, Choi KH, Han JH, Kim YD.
    Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):349-52. PubMed ID: 16234696
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L, Cancer and Leukemia Group B.
    J Clin Oncol; 2003 May 01; 21(9):1825-35. PubMed ID: 12721260
    [Abstract] [Full Text] [Related]

  • 38. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
    Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE.
    Ann Surg; 1999 Jul 01; 230(1):72-8. PubMed ID: 10400039
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 Jul 01; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 40. [Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].
    Sakurai K, Enomoto K, Tani M, Kitajima A, Amano S, Shiono M.
    Gan To Kagaku Ryoho; 2008 Nov 01; 35(12):2222-4. PubMed ID: 19106577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.